HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

6th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 28-30 | Hybrid Event

September 28-30, 2026 | London, UK

Biotechnology in Public Health

Biotechnology in Public Health

Biotechnology in public health plays a pivotal role in shaping the landscape of public health, offering innovative solutions and advancements that significantly impact disease prevention, diagnostics, and treatment. In the realm of public health, biotechnology contributes to the development of cutting-edge vaccines, therapeutic drugs, and diagnostic tools that enhance our ability to combat infectious diseases, chronic conditions, and emerging health threats. With the ability to manipulate biological systems at the molecular and cellular levels, biotechnology enables the creation of personalized and targeted interventions, paving the way for more effective and efficient public health strategies. Additionally, advancements in biotechnology facilitate the analysis of genetic data, leading to a deeper understanding of predispositions to diseases and allowing for more tailored public health interventions. The intersection of biotechnology and public health represents a dynamic and evolving field that holds great promise for addressing global health challenges and improving the overall well-being of communities.

Committee Members
Speaker at Biotechnology and Bioengineering 2026 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
Speaker at Biotechnology and Bioengineering 2026 - Limongi Tania

Limongi Tania

University of Turin, Italy
Speaker at Biotechnology and Bioengineering 2026 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico
Tags

Submit your abstract Today

Watsapp